Jessica Joyce Mistilis
Biographic Data
| ID | 9022760 |
|---|---|
| NAME | Jessica Joyce Mistilis |
| GIVEN NAMES | Jessica Joyce |
| FAMILY NAME | Mistilis |
| SIGNATURE | MISTILIS J J |
| AFFILIATIONS | Program for Appropriate Technology in Health |
| VERIFIED | No |
| TOTAL WORKS | 2 |
| TOTAL CITATIONS | 0 |
| AUTHOR COUNT | 2 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2022 |
| LATEST PUBLICATION YEAR | 2026 |
| H-INDEX | 0 |
Priority implementation research for measles-rubella microarray patches identified using the Child Health and Nutrition Research Initiative methodology
Background: Measles and rubella continue to be a significant global health challenge, disproportionately impacting marginalised communities in low- and middle-income countries (LMICs). Innovative technologies such as measles-rubella microarray patches (MR-MAPs) are currently in development and can potentially improve immunisation coverage and equity through their unique product characteristics. Nonetheless, the limited evidence around their use c…
Accelerating the Development of Measles and Rubella Microarray Patches to Eliminate Measles and Rubella
Measles and rubella microarray patches (MR-MAPs) are critical in achieving measles and rubella eradication, a goal highly unlikely to meet with current vaccines presentations. With low commercial incentive to MAP developers, limited and uncertain funding, the need for investment in a novel manufacturing facility, and remaining questions about the source of antigen, product demand, and regulatory pathway, MR-MAPs are unlikely to be prequalified by…
No prominent works on this page.
Accelerating the Development of Measles and Rubella Microarray Patches to Eliminate Measles and Rubella
Measles and rubella microarray patches (MR-MAPs) are critical in achieving measles and rubella eradication, a goal highly unlikely to meet with current vaccines presentations. With low commercial incentive to MAP developers, limited and uncertain funding, the need for investment in a novel manufacturing facility, and remaining questions about the source of antigen, product demand, and regulatory pathway, MR-MAPs are unlikely to be prequalified by…
Priority implementation research for measles-rubella microarray patches identified using the Child Health and Nutrition Research Initiative methodology
Background: Measles and rubella continue to be a significant global health challenge, disproportionately impacting marginalised communities in low- and middle-income countries (LMICs). Innovative technologies such as measles-rubella microarray patches (MR-MAPs) are currently in development and can potentially improve immunisation coverage and equity through their unique product characteristics. Nonetheless, the limited evidence around their use c…
Measles (2 works) · Virology and Viral Diseases (2 works) · Animal Disease Management and Epidemiology (1 works) · Animal Virus Infections Studies (1 works) · Business (1 works) · Child health (1 works) · Computer Science (1 works) · Economics (1 works) · Equity (law) (1 works) · Focus group (1 works)